FIELD: medicine.
SUBSTANCE: pharmaceutical composition for treating joint and bone tissue diseases contains a combination of active substances consisting of the glucosamine sulphate salt, chondroitin sulphate sodium salt, ibuprofen as a non-steroidal anti-inflammatory agent, additives from excipients and processing additives, wherein the additives optionally contain vitamins and a calcium-containing excipient. The group of inventions also concerns a method for preparing the above pharmaceutical composition.
EFFECT: enhancing the therapeutic effect of the pharmaceutical composition in relation to the common knowledge without increasing the number and severity of its side effects.
8 cl, 1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION STIMULATING REPARATIVE OSTEOGENESIS IN DOGS AND CATS | 2022 |
|
RU2785118C1 |
| COMBINATION OF A CHONDROPROTECTIVE AGENT WITH AN NSAID | 2017 |
|
RU2742172C2 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
| COMBINED CHONDROPROTECTIVE PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2381029C1 |
| COMBINED AGENT FOR INTRAARTICULAR ADMINISTRATION | 2017 |
|
RU2737380C2 |
| PHARMACEUTICAL AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2023 |
|
RU2813891C1 |
| COMBINED AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2024 |
|
RU2827069C1 |
| AGENT FOR TREATING ARTHROLOGICAL DISEASES IN LYOPHILIZED FORM FOR INJECTIONS | 2024 |
|
RU2827073C1 |
| COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS, OSTEOPOROSIS AND OSTEOARTHROSIS | 2013 |
|
RU2521227C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739184C1 |
